AI assistant
Sending…
Qualigen Therapeutics, Inc. — Director's Dealing 2015
Jun 26, 2015
35251_dirs_2015-06-25_0232a5c8-f09b-4ba6-b165-5d98a17ae3cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2015-06-24
Reporting Person: PROEHL GERALD T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-24 | Common Stock | P | 50000 | $5.00 | Acquired | 50000 | Direct |
More from Qualigen Therapeutics, Inc.
Board/Management Information
2026
May 28
Capital/Financing Update
2026
May 14
Annual Report
2026
Mar 30
Regulatory Filings
2026
Feb 27
Board/Management Information
2026
Feb 17
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 29
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 6
Audit Report / Information
2025
Dec 16
Proxy Solicitation & Information Statement
2025
Dec 15